Budget 2017-18: Hits & misses for healthcare sector
The Union Budget 2017-18 presented by Finance Minister Arun Jaitley on February 1 brought cheers to certain sections of the […]
News
AiMeD suggests new measures to boost medical devices after ‘unexciting’ Budget
The Union Budget 2017-18 has set good macro health targets but no concrete measures have been taken to accelerate medical […]
Union Budget 2017-18: New All India Institutes of Medical Sciences to be set-up in Jharkhand and Gujarat
The Union Minister for Finance and Corporate Affairs, Arun Jaitley while presenting the General Budget 2017-18 in Parliament today said […]
Moody’s affirms J&J’s Aaa rating
Moody’s Investors Service affirmed the ratings of Johnson & Johnson including the Aaa senior unsecured rating and the Prime-1 commercial […]
Care24 Launches Home Healthcare Services in NCR region
Care24, Indias leading home healthcare services provider, announced the launch of its home-based health offerings in NCR region, with a […]
Pfizer gets positive CHMP Opinion in Europe for XELJANZ
Pfizer Inc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted […]
Piramal Enterprises unit acquires portfolio of drugs from Mallinckrodt LLC
Piramal Enterprises Limited announced that its wholly owned Critical Care subsidiary in the UK has entered into an agreement to […]
Suven Life secures product patent in USA
Suven Life Sciences Ltd announced that the grant of one product patent from USA corresponding to the New Chemical Entities […]
Clove Dental buys Dentys to expand footprint in South India
In a move to expand its presence in South India, Clove Dental, one of Indias largest dental chains promoted by […]
DoP to organise India Pharma & India Medical Device 2017 next month
The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, along with Federation of Indian Chambers of Commerce and Industry […]
Moody’s changes outlook on Novartis Aa3 rating to negative
Moody’s Investors Service has revised to negative from stable the outlook on the Aa3 long-term ratings of Novartis AG (Novartis) […]
GST on healthcare will make medicare unaffordable: ASSOCHAM-TechSci study
The healthcare sector should be kept out of the purview of the Goods and Services Tax (GST) or else medical […]
NATCO updates on USFDA inspection at Kothur Formulation Facility
Natco Pharma Limited stated that an inspection was conducted by the United States Food & Drug Administration (USFDA) at its […]
